Skip to main content
. 2024 Sep 30;130(24):4188–4199. doi: 10.1002/cncr.34628

FIGURE 1.

FIGURE 1

(A) The common steps or diagnostic pathway patients undergo from suspicion of lung cancer to treatment for those with advanced non–small cell lung cancer and (B) barriers to comprehensive biomarker testing experienced by individual groups that were identified during the confessional session of the Summit on Optimizing Lung Cancer Biomarkers in Practice.